0001192482-20-000457.txt : 20200610 0001192482-20-000457.hdr.sgml : 20200610 20200610130218 ACCESSION NUMBER: 0001192482-20-000457 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 EFFECTIVENESS DATE: 20200610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Larimar Therapeutics, Inc. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368642 FILM NUMBER: 20954258 BUSINESS ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 BUSINESS PHONE: 844-511-9056 MAIL ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN, INC. DATE OF NAME CHANGE: 20100301 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 D 1 primary_doc.xml X0708 D LIVE 0001374690 Larimar Therapeutics, Inc. THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA PENNSYLVANIA 19004 844-511-9056 DELAWARE ZAFGEN, INC. ZAFGEN INC Corporation true Carole Ben Maimon, MD Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19004 Executive Officer Director President and CEO Michael Celano Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19044 Executive Officer Chief Financial Officer Joseph Truitt Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19004 Director Thomas Hamilton Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19004 Director Peter Barrett Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19004 Director Jonathan Leff Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19004 Director Thomas O. Daniel Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19004 Director Frank E. Thomas Three Bala Plaza East Suite 506 Bala Cynwyd PA PENNSYLVANIA 19004 Director Biotechnology Decline to Disclose 06b false 2020-05-28 false true true Issuance of shares pursuant to Agreement and Plan of Merger, dated December 17, 2019, as amended, by and among Larimar Therapeutics, Inc. (f/k/a Zafgen, Inc.), Zordich Merger Sub, and Chondrial Therapeutics, Inc. 0 82079593 82079593 0 false 1 0 0 0 false Larimar Therapeutics, Inc. /s/ Michael Celano Michael Celano Chief Financial Officer 2020-06-06